Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Pembrolizumab as first line treatment of Merkel cell carcinoma patients - a case series of patients with various co-morbidities

Publikation: Bidrag til tidsskriftLetterForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{1c3524c82845481fb90750522725ca52,
title = "Pembrolizumab as first line treatment of Merkel cell carcinoma patients - a case series of patients with various co-morbidities",
author = "{Bystrup Boyles}, Tessa and Mette Sch{\o}dt and Hendel, {Helle Westergren} and Anders Krarup-Hansen and Niels Junker",
year = "2020",
month = jul,
doi = "10.1080/0284186X.2020.1747637",
language = "English",
volume = "59",
pages = "793--796",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Informa Healthcare",
number = "7",

}

RIS

TY - JOUR

T1 - Pembrolizumab as first line treatment of Merkel cell carcinoma patients - a case series of patients with various co-morbidities

AU - Bystrup Boyles, Tessa

AU - Schødt, Mette

AU - Hendel, Helle Westergren

AU - Krarup-Hansen, Anders

AU - Junker, Niels

PY - 2020/7

Y1 - 2020/7

UR - http://www.scopus.com/inward/record.url?scp=85083569601&partnerID=8YFLogxK

U2 - 10.1080/0284186X.2020.1747637

DO - 10.1080/0284186X.2020.1747637

M3 - Letter

C2 - 32285728

VL - 59

SP - 793

EP - 796

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 7

ER -

ID: 61915083